Literature DB >> 8474108

Hereditary anaemias in Portugal: epidemiology, public health significance, and control.

M C Martins1, G Olim, J Melo, H A Magalhães, M O Rodrigues.   

Abstract

A countrywide prospective study aimed at establishing the prevalence of the haemoglobinopathy genes in the Portuguese population was carried out by screening 15,208 randomly selected blood samples from young males. This male based survey provided the opportunity of assessing simultaneously the prevalence of the red cell enzyme glucose-6-phosphate dehydrogenase (G6PD) deficiency, thus giving a picture of these important hereditary anaemias in Portugal. The results showed a low average frequency of beta thalassaemia (0.45%) and haemoglobin S (0.32%) carriers as well as G6PD deficiency (0.51%). However, these disorders are unevenly distributed throughout the country with a higher prevalence in some areas, mainly in the south. The relationship of this pattern of haemoglobinopathies to the known haplotypes linked to beta thalassaemia and sickle cell disease, relevant historical events, and local selective pressure was investigated. Hb D and Hb J are the commonest other structural variants. The implemented programme for control of these hereditary anaemias is described.

Entities:  

Mesh:

Year:  1993        PMID: 8474108      PMCID: PMC1016307          DOI: 10.1136/jmg.30.3.235

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  7 in total

1.  Importation route of the sickle cell trait into Portugal: contribution of molecular epidemiology.

Authors:  J Lavinha; J Gonçalves; P Faustino; L Romão; L Osório-Almeida; M J Peres; I Picanço; M C Martins; R Ducrocq; D Labie
Journal:  Hum Biol       Date:  1992-12       Impact factor: 0.553

2.  Estimation of small percentages of foetal haemoglobin.

Authors:  K BETKE; H R MARTI; I SCHLICHT
Journal:  Nature       Date:  1959-12-12       Impact factor: 49.962

3.  Beta-thalassemia mutations in the Portuguese population.

Authors:  M P Gomes; M G da Costa; L B Braga; N T Cordeiro-Ferreira; A Loi; M Pirastu; A Cao
Journal:  Hum Genet       Date:  1988-01       Impact factor: 4.132

4.  Haemoglobin J Paris in the south of Portugal (Algarve).

Authors:  C Trincao; J M De Melo; P A Lorkin; H Lehmann
Journal:  Acta Haematol       Date:  1968       Impact factor: 2.195

5.  The frequency and origin of the sickle cell mutation in the district of Coruche/Portugal.

Authors:  C Monteiro; J Rueff; A B Falcao; S Portugal; D J Weatherall; A E Kulozik
Journal:  Hum Genet       Date:  1989-06       Impact factor: 4.132

6.  Novel promoter and splice junction defects add to the genetic, clinical or geographic heterogeneity of beta-thalassaemia in the Portuguese population.

Authors:  P Faustino; L Osório-Almeida; J Barbot; D Espírito-Santo; J Gonçalves; L Romão; M C Martins; M M Marques; J Lavinha
Journal:  Hum Genet       Date:  1992-07       Impact factor: 4.132

7.  Beta + thalassemia--Portuguese type: clinical, haematological and molecular studies of a newly defined form of beta thalassaemia.

Authors:  G P Tamagnini; M C Lopes; M E Castanheira; J S Wainscoat; W G Wood
Journal:  Br J Haematol       Date:  1983-06       Impact factor: 6.998

  7 in total
  3 in total

1.  Novel point mutation in exon 12 of the glucose-6- phosphate dehydrogenase gene: G6PD FLORES.

Authors:  Maria-Odete Rodrigues; Júlia Dias Pereira; Gisela Gaspar; Gabriel Olim; Maria-Do-Carmo Martins; Carolino Monteiro
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

2.  The role of HFE mutations on iron metabolism in beta-thalassemia carriers.

Authors:  Rute Martins; Isabel Picanço; Aidil Fonseca; Lídia Ferreira; Odete Rodrigues; Marília Coelho; Teresa Seixas; Armandina Miranda; Baltazar Nunes; Luciana Costa; Luísa Romão; Paula Faustino
Journal:  J Hum Genet       Date:  2004-11-05       Impact factor: 3.172

3.  Global epidemiology of haemoglobin disorders and derived service indicators.

Authors:  Bernadette Modell; Matthew Darlison
Journal:  Bull World Health Organ       Date:  2008-06       Impact factor: 9.408

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.